Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
SR 202, Tocris Bioscience™
Click to view available options
Quantity:
10 mg
50 mg
Description
Selective PPARγ antagonist; antidiabetic and antiobesity agent. Attenuates troglitazone-induced PPARγ transcriptional activity (IC50 = 140 μM) without affecting ligand-stimulated PPARα, PPARβ or FXR transcriptional activity. Inhibits PPARγ-dependent adipocyte differentiation and growth in vitro and in vivo. Improves insulin sensitivity in diabetic ob/ob mice and increases HDL levels in rats in vivo.
Specifications
Specifications
Quantity | 50 mg |
Formula Weight | 358.65 |
Percent Purity | >99% |
Chemical Name or Material | SR 202 |
Safety and Handling
Recommended Storage | Desiccate at Room Temperature |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction